Filing Flows › Progyny (PGNY) › Pharmacy benefits services revenue revenue
Progyny (PGNY) Pharmacy benefits services revenue revenue by quarter
Progyny's Pharmacy benefits services revenue revenue was $118M in Q3 2026 (third quarter 2026), -2% from Q2 2026. Over the last 7 quarters it ranged from $110M (Q4 2025) to $120M (Q2 2026).
| Quarter | Pharmacy benefits services revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $118M | -2% | +6% |
| Q2 2026 | $120M | +1% | +1% |
| Q1 2026 | $119M | +8% | +1% |
| Q4 2025 | $110M | -1% | — |
| Q3 2025 | $111M | -6% | — |
| Q2 2025 | $119M | +1% | — |
| Q1 2025 | $118M | — | — |
Q3 2026 at a glance
Progyny, Q3 2026: revenue $341M (+9% year over year), operating margin 10.3%, net earnings $26.3M, operating cash flow $56.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Progyny's Pharmacy benefits services revenue revenue?
Progyny's Pharmacy benefits services revenue revenue was $118M in Q3 2026 (third quarter 2026), -2% from Q2 2026.
How has Progyny's Pharmacy benefits services revenue revenue changed?
Over the last 7 quarters it ranged from $110M (Q4 2025) to $120M (Q2 2026).